| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 217.6 | 267.8 |
| Gross profit | 101.5 | 154.9 |
| Profit before tax | 72.5 | 123.9 |
| Net income | 40.2 | 55.4 |
| EPS (diluted, $ a share) | $5.71 | $7.76 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -27.4% |
|---|---|
| Revenue, year on year | -18.7% |
| Gross margin | 46.7% |
| Operating margin | 35.4% |
10-Q filed with the SEC, NASDAQ: NUTX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Nutex Health Inc.: key numbers
- Share price
- $169.70Close, Nov 16
- Market cap
- $1.16B
- Shares outstanding
- 6.86MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Services-Business Services, NECSIC 7389
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Nutex Health Inc.
All →Nutex Health Dividend
Nutex Health's Board of Directors declared a special cash dividend of $2.00 per share, marking the company's first dividend since going public. The dividend is payable on December 14, 2026, to stockholders of record as of November 30, 2026, and management intends to recommend future regular quarterly dividends.
Nutex Health Financial Results
Nutex Health reported third quarter 2026 financial results, including net income of $40.2 million and total revenue of $217.6 million. While hospital division visits increased 18.1% year-over-year, total revenue decreased 18.7% primarily due to favorable revenue recognition adjustments that occurred in the prior year period.
- Term
- Q3 2026
Nutex Health Insider Scott J. Saunders Sells $43.5K of Stock
Scott J. Saunders sold 203 shares of Nutex Health Inc. at $214.25 a share, worth $43.5K in total on Sep 18, 2026. Shares held after the trade: 400 (-33.7%).
- Value
- $43.5K
- Shares
- 203
- Price
- $214.25
- Holding change
- -33.7%
- Trade date
- Sep 18, 2026